Cosentyx (secukinumab) is a prescription drug used to treat certain types of arthritis and other conditions. The drug comes as a liquid solution inside single-use pens, syringes, and vials. It may be ...
The approval was based on data from two phase 3 trials that evaluated the use of Cosentyx in patients 6 to 18 years of age with severe plaque psoriasis who were candidates for systemic therapy. The ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved secukinumab for the treatment of active psoriatic arthritis in patients aged 2 years and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results